D. Ferry
Impact in
- Drug Discovery top 5%
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 21
- Colorectal Cancer Treatments and Studies 10
- Drug Transport and Resistance Mechanisms 6
-
- Gastric Cancer Management and Outcomes 10
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Hartmut H. Glossmann (14 shared papers)A. Göll (11 shared papers)David Walter Fyfe (3 shared papers)Heidi Traunecker (2 shared papers)Rachel S. Kerr (2 shared papers)Adam J. de Smith (1 shared paper)David J. Kerr (7 shared papers)David James Kerr (1 shared paper)
- Journals
- Annals of Oncology (21 papers)European Journal of Cancer (8 papers)British Journal of Cancer (7 papers)FEBS Letters (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
D. Ferry
74 papers receiving 4k citations
D. Ferry's Hit Papers
Peers
Comparison fields: 5 of 109
- Drug Discovery 14
- Oncology 935
- Biochemistry 214
- Biomaterials 368
- Pulmonary and Respiratory Medicine 788
Countries citing papers authored by D. Ferry
This map shows the geographic impact of D. Ferry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ferry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ferry more than expected).
Fields of papers citing papers by D. Ferry
This network shows the impact of papers produced by D. Ferry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ferry. The network helps show where D. Ferry may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Ferry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Hit paper breakdown → | 1996 | 567 |
| 2 | 1999 | 370 | |
| 3 | Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer Hit paper breakdown → | 2016 | 333 |
| 4 | 2004 | 326 | |
| 5 | 1996 | 191 | |
| 6 | 2017 | 165 | |
| 7 | 2001 | 143 | |
| 8 | [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. | 1981 | 123 |
| 9 | 1984 | 113 | |
| 10 | 2016 | 113 | |
| 11 | 2017 | 101 | |
| 12 | 1994 | 99 | |
| 13 | 1998 | 99 | |
| 14 | 1997 | 93 | |
| 15 | 2001 | 92 | |
| 16 | 1983 | 91 | |
| 17 | 2017 | 87 | |
| 18 | 2013 | 70 | |
| 19 | 2013 | 58 | |
| 20 | 1984 | 57 |
About D. Ferry
D. Ferry is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Analytical Chemistry and Pharmacology, having authored 76 papers that have together received 4.3k indexed citations. Recurring topics across this work include Ion channel regulation and function (16 papers), Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (10 papers), Lung Cancer Treatments and Mutations (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Esophageal Cancer Research and Treatment (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). The work is most often cited by research in Drug Discovery (14 citations), Oncology (935 citations), Biochemistry (214 citations), Biomaterials (368 citations) and Pulmonary and Respiratory Medicine (788 citations). D. Ferry has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Hartmut H. Glossmann, A. Göll, David Walter Fyfe, Heidi Traunecker, Rachel S. Kerr, Adam J. de Smith, David J. Kerr, David James Kerr, Friedrich Lübbecke and Peter Bellemann. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, FEBS Letters and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.